Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan

Clinical trial NCT01263496 · COMPLETED

Trial details

NCT number: NCT01263496
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2007-05-01
Primary completion: 2008-09-01
Enrollment: 438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.